Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study

Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study

Objectives: The prevalence and risk factors of SARS-CoV-2 infection among unvaccinated people living with HIV (PWH) are not well understood, and the protective role of tenofovir remains controversial. This study aimed to assess the SARS-CoV-2 prevalence and associated risk factors among unvaccinated...

Full description

Saved in:
Bibliographic Details
Main Authors: Elisa de Lazzari, Daniel K. Nomah, Jose L. Blanco, Naira Rico, Xabier Filella, Natalia Egri, Raquel Ruiz, Maria Angeles Marcos, Maria del Mar Mosquera, Jose Alcamí, Sonsoles Sánchez-Palomino, Andreu Bruguera, Carmen Hurtado, Cristina Rovira, Juan Ambrosioni, Iván Chivite, Ana González-Cordón, Alexy Inciarte, Montserrat Laguno, María Martínez-Rebollar, Lorena de la Mora, Berta Torres, Yesika Díaz, Esteban Martínez, Josep Mallolas, Jose M. Miro
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:International Journal of Infectious Diseases
Subjects:
HIV
SARS-CoV-2, COVID-19, Prevalence, Risk factors, Antiretroviral therapy, Tenofovir, Prognosis
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971224003370
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1201971224003370

Similar Items